275 related articles for article (PubMed ID: 32673663)
1. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs.
Aslan C; Maralbashi S; Kahroba H; Asadi M; Soltani-Zangbar MS; Javadian M; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
Life Sci; 2020 Oct; 258():118094. PubMed ID: 32673663
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis.
Ghaffari-Makhmalbaf P; Sayyad M; Pakravan K; Razmara E; Bitaraf A; Bakhshinejad B; Goudarzi P; Yousefi H; Pournaghshband M; Nemati F; Fahimi H; Rohollah F; Hasanzad M; Hashemi M; Mousavi SH; Babashah S
Life Sci; 2021 Jan; 264():118719. PubMed ID: 33159957
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line.
Elieh Ali Komi D; Shekari N; Soofian-Kordkandi P; Javadian M; Shanehbandi D; Baradaran B; Kazemi T
Clin Nutr ESPEN; 2021 Dec; 46():477-483. PubMed ID: 34857238
[TBL] [Abstract][Full Text] [Related]
10. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
12. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
13. Horizontal transfer of miR-23a from hypoxic tumor cell colonies can induce angiogenesis.
Sruthi TV; Edatt L; Raji GR; Kunhiraman H; Shankar SS; Shankar V; Ramachandran V; Poyyakkara A; Kumar SVB
J Cell Physiol; 2018 Apr; 233(4):3498-3514. PubMed ID: 28929578
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells.
Maralbashi S; Aslan C; Kahroba H; Asadi M; Soltani-Zangbar MS; Haghnavaz N; Jadidi F; Salari F; Kazemi T
BMC Nutr; 2024 Mar; 10(1):41. PubMed ID: 38439112
[TBL] [Abstract][Full Text] [Related]
15. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
16. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.
Hsu YL; Hung JY; Chang WA; Lin YS; Pan YC; Tsai PH; Wu CY; Kuo PL
Oncogene; 2017 Aug; 36(34):4929-4942. PubMed ID: 28436951
[TBL] [Abstract][Full Text] [Related]
19. Use of cellular exosomes as a new carrier in breast cancer gene therapy.
Maleki N; Mirhakimi S; Babashah S; Sayadi A; Parnian G; Hadizadeh M
Klin Onkol; 2021; 34(4):300-305. PubMed ID: 34649440
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic enhancement of exosome release by breast cancer cells.
King HW; Michael MZ; Gleadle JM
BMC Cancer; 2012 Sep; 12():421. PubMed ID: 22998595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
